MedTrace Logo

Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis

NCT05062395 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2023-04-10

No results posted yet for this study

Summary

This study evaluates positron emission tomography for the diagnosis of immune checkpoint inhibitor-related myocarditis. Immune checkpoint inhibitors have shown promising results in various malignancies however, several immune related adverse events have been described of which myocarditis carries the highest reported mortality. Diagnostic procedures, such as positron emission tomography, help find and diagnose myocarditis and provide functional or disease activity information as opposed to the largely structural/anatomic information.

Conditions

  • Myocarditis Acute

Interventions

PROCEDURE

Computed Tomography

Undergo FDG PET CT

OTHER

Fludeoxyglucose F-18

Undergo FDG PET CT

OTHER

Low Carbohydrate High Fat Diet

low carbohydrate and high fat diet for 48-72 hours

PROCEDURE

Positron Emission Tomography

Undergo FDG PET CT

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Nicolas L Palaskas, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-30
Primary Completion
2023-04-04
Completion
2023-04-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05062395 on ClinicalTrials.gov